Tech Company Financing Transactions
N-Power Medicine Funding Round
N-Power Medicine closed a $32 million Series B investment round on 9/2/2026. Investors included Innovatus Capital Partners, LabCorp and Merck Global Health Innovation Fund.
Transaction Overview
Company Name
Announced On
9/2/2026
Transaction Type
Venture Equity
Amount
$32,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to scale its community oncology research network, deepen pharma partnerships, and continue investing in product development, including expanding its Prospective External Control Arm (ProECA) programs into colorectal and prostate cancer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2221 Broadway
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
N-Power and its purpose-built clinical research platform empowers oncology practices and biopharma companies to accelerate drug development and make better-informed decisions. N-Power catalyzes clinical research by equipping oncology practices with the N-Power Platform and connecting them to industry research sponsors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Lee
Co-Founder
Christer Svedman
VP - Administration
Maria Ferrari
VP - Bus. Development
Dan Schneider
VP - General Counsel
Ruchika Kumar
VP - Regulatory Affairs
Emily Luvison
Browse more venture capital transactions:
Prev: 9/2/2026: Huskeys venture capital transaction
Next: 9/2/2026: Remedium Network venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs